Expression of TCEAL2 is a Novel Prognostic Biomarker and Potential Therapeutic Target in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
TCEAL2 is a potential prognostic biomarker and therapeutic target in CESC. Further research is needed to explore its role and clinical applications.
Authors
- Z. Ye (ORCID: https://orcid.org/0009-0004-9626-7849)
- Jinyuan Li (ORCID: https://orcid.org/0009-0002-4341-6383)
- Dongbing Li (ORCID: https://orcid.org/0000-0002-5227-9643)
- Yibiao Chen (ORCID: https://orcid.org/0000-0002-9268-4950)
- Yuhong Gan (ORCID: https://orcid.org/0009-0009-0240-7983)
Institutions
- Meizhou City People's Hospital (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-08-28
- DOI
- https://doi.org/10.2174/0109298673371499250714133701
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00